Adalta Capital Management’s Gilead Sciences GILD Stock Holding History

Adalta Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,000	Closed	-$190K	–	80
2020 Q3	$190K	Hold	3,000	–	–	0.14%	66
2020 Q2	$231K	Hold	3,000	–	–	0.18%	52
2020 Q1	$224K	Buy	+3,000	New	+$207K	0.2%	56
2019 Q3	–	Sell	-3,000	Closed	-$203K	–	86
2019 Q2	$203K	Buy	+3,000	New	+$197K	0.13%	79
2018 Q4	–	Sell	-3,000	Closed	-$232K	–	75
2018 Q3	$232K	Hold	3,000	–	–	0.17%	72
2018 Q2	$213K	Hold	3,000	–	–	0.15%	72
2018 Q1	$226K	Hold	3,000	–	–	0.17%	68
2017 Q4	$215K	Hold	3,000	–	–	0.16%	69
2017 Q3	$243K	Hold	3,000	–	–	0.2%	67
2017 Q2	$212K	Hold	3,000	–	–	0.17%	72
2017 Q1	$204K	Buy	+3,000	New	+$211K	0.17%	70

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Adalta Capital Management's GILD Position: Q4 2020 in Review

Adalta Capital Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 3,000 shares — an estimated $190K sold.

Adalta Capital Management first reported a position in GILD in Q1 2017 and held it in 11 quarters. The position peaked at $243K in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Adalta Capital Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Adalta Capital Management sold 3,000 Gilead Sciences shares in Q4 2020, an estimated $190K.
Adalta Capital Management first reported a position in Gilead Sciences in Q1 2017 and held it in 11 quarters.
Adalta Capital Management's Gilead Sciences position peaked at $243K in Q3 2017.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Adalta Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.